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Abstract 
 
 
Introduction 
Moxibustion is an ancient method of traditional medicine (along with acupuncture) using moxa, or 
processed mugwort leaves. Both the smoke and heat generated by burning moxa are considered to 
have therapeutic effects. However, recently there have been reports of harmful substances released 
in smoke from everyday objects such as scented candles or incense. Therefore, it appeared to be 
important to evaluate the safety of products resulting from the combustion of moxa.  
 
Methods 
We used three types of commonly used moxa. Experiments were conducted by lighting moxa which 
had been classified according to their level of refinement. Gases released were collected after 
igniting moxa. A gas chromatograph mass spectrometer (GC/MS) was used for both qualitative and 
quantitative analysis. Standard conditions for Japanese therapeutic environments were employed.  
 
Results 
1,3-butadiene was present from the smoke at the highest level of concentrations of substances 
governed by assorted indoor air quality and environmental standards (1,3-butadiene, benzene, 
toluene, ethylbenzene, and xylene) and fell below maximum values. Also, simulationin an indoor 
environment with 1,3-butadiene was safely within indoor environmental standards. 
 
Conclusion 
Our simulation results have shown that quantities of harmful substances released upon combustion 
of moxa during normal clinical therapy of Japan are below maximum levels. Hence are safe for both 
patient and practitioner. However we detected few amounts of harmful substances released from 
moxa. These harmful substances are invariably generated upon combustion, although varieties and 
quantities vary according to substance. So measures to maintain an appropriately safe work 
environment must be practiced, even though safety was confirmed.  
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1. Background 
Traditional medicine’s acupuncture and moxibustion began in ancient times in China, and were 
transmitted largely within East Asia, where throughout the ages techniques were passed down in a 
closely-knit relationship with local traditions and customs. Moxibustion originally was considered to 
be performed with materials other than moxa or methods to expose affected parts of the body to 
smoke
1,2
, but mugwort leaves came to be the final source of heat. Not only is mugwort a common 
plant and thus easily procured, but dried leaves of the plant burn in a steady and pleasing manner. 
Smoke released upon burning of the leaves also has a pleasant fragrance, which has been reported to 
have a variety of effects
3
. This smoke is believed to have sterilization effect
4
 in China, and basic 
research of its effect has been published
5
.   
 
Many combustion products are released in smoke when moxa burns, although the same can be said 
of any substance. Such combustion products may include substances both innocuous and harmful to 
humans, although even harmful substances may be handled in such a way as to render them 
innocuous. National standards governing such substances can vary according to country, but there 
exist environmental and safety standards requiring that any products exported must comply with. 
Examples are formaldehyde and 1,3-butadiene, well-known carcinogenic combustion products 
released upon burning of a multitude of everyday goods. M. Derudi
6
 et al. have studied the toxicity 
of candles containing chemical substances such as fragrances.  
 
In recent years there have been efforts to standardize moxibustion implements and techniques 
throughout the world, accompanied by a growing recognition of the need to bring modern scientific 
analysis to bear on the treatments. There have already been studies of the constituent ingredients of 
the base ingredient mugwort and the processed substance moxa
7
. However, there has been no such 
analysis of the constituent products of smoke released upon burning moxa
8,9
. In particular, there 
have been no reports on the safety of smoke from moxa produced in Japan.  
Therefore, in this study we analyzed the substances contained in smoke released from moxa upon 
combustion, compared these with relevant standards, and performed a simulation on practitioner 
exposure.  
 
2. Materials and Methods 
2.1 Materials 
We used three types of moxa, each refined to a different degree: Tenkyu, Kyutoshin, and Onkyu. In 
Japanese moxibustion practice, these three types of moxa are used with different techniques 
according to therapeutic goals
10,11
. Type of moxa used primarily depends upon degree of refinement 
(Fig.1). Differing degrees of refinement generate different quantities of heat, and different treatments 
require different temperatures. A lower degree of refinement moxa means a higher level of foreign 
substances in the leaves, causing higher temperatures upon combustion.  
 
High-refined moxa is used with Tenkyu treatment methods, which are practiced primarily in Japan. 
In this treatment, a moxa cone (twisted moxa for combustion), with about half- to full-size of a rice 
grain, is placed directly on the skin and gives small burn with an incense stick. High-refined moxa is 
manufactured by first grinding the leaves in a stone mill, then bamboo implements known as 
Nagatoshi and grain fans combined with sieves to produce the final product. This type of moxa 
requires a trained and experienced craftsman to produce, and is golden in color. About 100 kg of 
dried mugwort leaves yields about 3 kg of Tenkyu moxa.  
 
Medium-refined moxa is used in Kyutoshin and Chinetsu-kyu therapy methods. In Kyutoshin, moxa 
is affixed to the handle of the needle inserted into the patient, then burned to heat the skin through 
radiant heat. Chinetsu-kyu therapy may use either a moxa tube or a cardboard base to provide an 
indirect thermal stimulus to the skin. About 100 kg of dried mugwort leaves yields about 15 kg of 
the medium-refined moxa.  
 
Finally, low-refined moxa is used in Onkyu therapy, a method to warm the affected part with radiant 
heat using larger moxa cones than those for Tenkyu or moxa sticks, or indirect heat with medical 
herbs placed between a moxa cone and the skin. Therefore, relatively un-refined moxa is used as it 
provides a higher temperature upon combustion. About 100 kg of dried mugwort leaves yields about 
30 kg of this type of moxa.  
 
In this study we used three types of moxa of different grades produced by a major Japanese producer 
of moxa for clinical use. Sample 1 (S1) was high-refined moxa (Tenkyu), sample 2 (S2) was 
medium-refined moxa (Kyutoshin), and sample 3 (S3) was low-refined moxa (Onkyu).  
 
Study measurements were performed by the Chemicals Evaluation and Research Institute, Japan. 
 
3 Methods 
We collected smoke for qualitative analysis of the materials released from the smoke. Only 
substances governed by the environmental standards were subjected to the quantitative analysis and 
measurement of the density. In addition, we measured the density of carbon monoxide (CO) and 
carbon dioxide (CO2) by gas-detecting tube test. These results were subsequently used to perform a 
simulation of exposure to the substances. 
 
3.1 Test method 
3.1.1 Qualitative analysis 
S1, S2 and S3 were ignited, placed in a glass combustion chamber, then subjected to a high-purity 
air stream produced by a mass flow controller (75 mL/min for S1 and 500 mL/min for S2 and S3). 
Gasses released from the combustion chamber were captured in a Tedlar bag. Gas collected in this 
manner was then aliquoted with a gas-tight syringe (1 mL, or 5 mL for low-concentration samples) 
and transferred to a gas chromatograph mass spectrometer (GC/MS) with a liquid argon cold trap at 
the column entrance. After concentration, the liquid argon container was removed from the 
thermostatic bath and heated rapidly to perform qualitative analysis.  
 
3.1.2 Quantitative analysis 
Next, quantitative analysis was performed on substances identified from the qualitative analysis 
which are particularly harmful and regulated according to standards or guidelines concerning indoor 
air quality or environmental pollution (1,3-butadiene, benzene, toluene, ethylbenzene, xylene, CO, 
and CO2). Quantities of these substances were evaluated according to the following standards: 
Japan’s Law for Maintenance of Sanitation in Buildings
12
, the UK’s air quality standards
13
, Japanese 
Ministry of the Environment’s (MOE) environmental regulations
14
, and the Japanese Ministry of 
Health, Labor, and Welfare’s (MHLW) indoor concentration guideline values
15
. The Japanese indoor 
concentration values for chemical substances are “Chemical substance concentrations below which 
even a lifetime of exposure should result in no harmful effects, as based on currently available 
scientific evidence.”  
 
3.1.3 Detector tube test 
 Gas sampling pump: GV-100S 
 CO rapid detector tube No. 1L (Gastec) 
 CO2 rapid detector tube: No. 2L (Gastec)  
 
3.2 Reagents and equipment 
 Air: Purified Air G-3(Japan Fine Products) 
 Tedlar bag: 3 L type A (Omi Odor-Air Service) 
 Mass flow controller: SEC-40 (Horiba Stech) 
 
3.3 Combustion test 
3.3.1 Combustion device 
A schematic of the combustion device used is shown in Figure 2.  
A preliminary cleaning of the combustion chamber was performed with water and methanol, then it 
was further cleaned with a heat gun while passing through 1 L/min air for approximately 20 minutes.  
 
3.4 Samples 
Experiments used moxa samples of the same size and shape generally used in clinical situations in 
Japan in order to best reflect actual use
10,11
.  
 
Towards this end, for S1 (high-refined moxa for Tenkyu) two cones of about 1 mg each were placed 
side-by-side (Fig.3), while for S2 (medium-refined moxa for Kyutoshin) and S3 (low-refined moxa 
for Onkyu) 40 mg cones were used (Fig.4).  
 
3.4.1 Sample 1 
One mg of sample was precisely measured out and shaped into a cone; two of these were placed on a 
stand and ignited with an electrical filament before being placed in the combustion chamber. A mass 
flow controller was used to blow high-purity air adjusted to 50% RH over the samples for exactly 1 
minute at a flow rate of 75 mL/min. This operation was repeated five times, and the gas released 
trapped in gas collection bags to be used as samples for measurement. This entire process was 
performed two times for a total of ten data calculations.  
 
Gas was collected according to the same process without igniting the samples as a control. Figure 5 
shows the moxa combustion methods.  
 
3.4.2 Sample 2 and Sample 3 
Forty mg of sample was precisely measured out, shaped into a cone, then placed on a stand before 
being ignited with an electrical filament and placed in the combustion chamber. A mass flow 
controller was used to blow high-purity air over the samples for exactly 3 minutes at a flow rate of 
500 mL/min. Gas released was trapped in Tedlar bags to be used as samples for measurement.  
 
Before measuring these samples, the same process was used on S2 without igniting the moxa to 
obtain control samples. Figure 5 shows the moxa combustion methods. 
 
3.5 Measurement conditions 
3.5.1 Gas chromatography/gas chromatograph mass spectrometer (GC/MS) measurement conditions  
 Device: 5973MSD (Agilent Technologies) 
 Column: Equity-1 (SUPELCO), diameter 0.32 mm, length 60 m, membrane thickness 5.0 μm 
 Column temperature: 40°C for 7.0 minutes (5°C/min.), then 20°C (20°C/min.), then 250°C (for 
2.5 min.)   
 Sample insertion point: 250°C 
 Sample injection volume: 1.0 mL 
 Sample insertion method: Splitless injection with cold trap at temperature of liquid argon. 
Analysis initiated 2 minutes after column head pressure returned to room temperature value 
(120 kPA) (about 5 minutes).   
 Carrier gas: Helium (1.2 mL constant flow mode) 
 
3.5.2 Gas chromatography / flame ionization detector (GC/FID) measurement conditions 
 Device: 6890N (Agilent Technologies), 
 Column: Equity-1 (SUPELCO) diameter 0.32 mm, length 60 m, membrane thickness 5.0 μm 
 Column temperature: 40°C for 7.0 minutes (5°C/min.), then 20°C (20°C/min.), then 250°C (for 
2.5 min.)   
 Sample insertion point: 250°C 
 Sample injection volume: 5 mL 
 Sample insertion method: Splitless injection with cold trap at temperature of liquid argon. 
Analysis initiated 2 minutes after column head pressure returned to room temperature value 
(120 kPA) (about 5 minutes).   
 Carrier gas: Helium (1.2 mL constant flow mode) 
 
3.6 Simulation of indoor air concentration during therapy 
 Based upon the results obtained above, simulations of indoor air concentration during moxibustion 
therapy were performed for 1,3-butadiene, which was the highest-concentration substance detected 
(among 1,3-butadiene, benzene, toluene, ethylbenzene, and xylene). Exposure levels were calculated 
according to measurements obtained from S2, as this sample resulted in the highest levels.   
 
3.6.1 Exposure scenario 
The scenario assumes moxibustion therapy in a room with a volume of 20 m
3
, with no transdermal 
exposure, only inhalation of smoke and its constituent combustion products. If moxa less than 
medium-refined is burned directly on the skin, complete combustion can cause scarring because 
about 40 mg of moxa is used. Therefore, recently in Japan the moxa is removed from the skin and 
extinguished as soon as it reaches therapeutic temperatures.  
 
Therefore, we assumed a combustion ratio of 63% for each piece of moxa in our simulation of the 
combustion product 1,3-butadiene. Eighteen pieces of 40-mg moxa were used in one treatment. Each 
piece burns for 30 seconds, so the entire combustion time is 9 minutes. We assume that therapy 
rooms will either have a ventilation system or windows, resulting in 0.5 air changes per hour in the 
simulated therapy room with volume of 20 m
3
.  
 
3.6.2 Algorithm 
Figure 6 shows concentration of 1,3-butadiene in indoor air during a therapy session: repeated 
combustion causes elevated concentrations which taper off as the treatment ends, followed by a 
decrease due to ventilation. The formula for calculating Cati (average air concentration of exposure 
duration) is shown in Figure 7. Concentration during use, Cai must incorporate factors such as 
elevation of concentration during combustion and decrease due to ventilation, which is shown as an 
algorithm in Figure 8. Finally, Figure 9 shows the algorithm Catii (average air concentration during 
post-use stay). 
 
4. Results 
4.1. Qualitative results 
Qualitative analysis of volatile organic compounds present in moxa combustion smoke after burning 
40 mg of each sample showed 66 compounds in S1, 99 in S2, and 102 in S3. Table 1 shows a list of 
compounds detected in S3.  
 
5. Quantitative results 
1) Results of detector tubes measurement 
Table 2 shows detector tube measurements for CO2 and CO. These levels assume a 20 m
3
 therapy 
room volume with no ventilation. S1 values were converted to those representing about 40 mg in 
order to enable comparison with S2 and S3.  
Figures for S2 and S3 in Table 1 were measured twice each. These concentrations were evaluated 
according to Japan’s Law for Maintenance of Sanitation in Buildings, the statutes which govern 
these substances. The law stipulates 1000 ppm or below for CO2 and 10 ppm or below for CO. As 
Table 2 shows, S1, S2, and S3 yielded concentrations below the regulated maximum (average of two 
measurements).  
 
2) Results of volatile organic compounds analysis 
Table 3 shows concentrations of substances regulated by various standards and policies governing 
indoor air and environmental pollution (1,3-butadiene, benzene, toluene, ethylbenzene, and xylene), 
as well as converted concentrations of these assuming a non-ventilated treatment area of 20 m
3
. S1 
values were converted to those representing about 40 mg in order to enable comparison with S2 and 
S3 (average of two measurements used).  
Table 2 shows substance concentrations according to various standards, which differ according to 
entity. As shown in Table 3, all samples resulted in concentrations within standard limits (average of 
two measurements).  
 
6. Results of simulation of indoor air concentration during therapy 
The formulae described above were used to calculate concentrations over time.  
 Cati = 6.76 μg/m
3
 (average air concentration of exposure duration)  
 
Cai = 13.3 μg/m
3
 (concentration at time of use)  
 Catii = 9.89 μg/m
3
 (average air concentration during post-use stay)  
The final formula used for calculating average air concentrations over time from beginning to end of 
therapy is as follows:  
 (Cai×ti+ Catii×tii) / (ti+tii)＝0.0103 mg/m3 (10.3 μg/m3) 
The threshold limit value – time-weighted average (TLV-TWA) for 1,3-butadiene according to the 
American Conference of Governmental Industrial Hygienists is 4.4 mg/m
3
 (2 ppm). Therefore, levels 
detected in our study are not considered problematic.  
 
7. Discussion 
This study evaluated the composition of smoke produced by three grades of Japanese moxa with 
difference in refinement degree and used in regular clinical moxibustion in Japan. We examined the 
ingredient of the smoke at the time of the combustion. 
In order to enable comparisons, we performed the examination under the worst environment, with no 
ventilation in calculating simple estimates of harmful combustion products in each sample. However, 
to develop the exposure scenario for simulation, we assumed and calculated under the actual clinical 
environment which could ventilate by a ventilation fan or windows. That complies with the structure 
and facility standards
16
 regulating acupuncture and moxibustion therapy rooms which dictate that “at 
least one-seventh of the therapy room’s area be open to outside air, or use an equivalent ventilation 
system.”  
 
Our experiments used 1 mg of S1 and 40 mg each of S2 and S3, reflecting actual clinical quantities. 
In preliminary experiments we used 40 mg of S1 as well, resulting in higher concentrations of 
1,3-butadiene and benzene released than either S2 or S3, although still below the maximum 
standards assuming an unventilated 20 m
3
 therapy room. These values were higher for S1 because its 
higher level of purification resulted in finer, denser plant fibers. Therefore, it may be assumed that 
when a 40 mg cone of moxa is burned in the same manner as our preliminary experiments, air does 
not reach the core of the cone, causing incomplete combustion. Therefore, S1 was prepared to have 
1/20 of quantity and an increased ratio of surface area by dividing in half. This quantity of 1 mg for 
S1 conforms to that used in medical practice. In addition, we changed flow volume and the 
ventilation time with S2 and S3 at the time of the examination. Nevertheless, the ventilation volume 
per 1 mg of sample was maintained at 37.5 ml/g under the same condition. 
 
Levels of CO2 and CO released upon moxa combustion were below Japanese environmental 
standards, and were not problematic. Meanwhile, volatile organic compounds were evaluated 
according to UK environmental standards, as Japan lacks such standards for 1,3-butadiene. 
Measurement results showed acceptable levels of 1,3-butadiene, benzene, toluene, ethylbenzene, and 
xylene. The aldehydes formaldehyde, acetaldehyde, and acrolein were detected, but quantitative 
analysis of all three samples demonstrated that levels generated fell below WHO guidelines
17
 as well 
as MHLW’s indoor concentration guideline values
15
.  
 
Harmful substances may be released upon either complete or incomplete combustion. Recent years 
have seen increasing study of indoor air pollution arising from a multitude of familiar, everyday 
sources, from wood stoves
18, 19
 to incense
20, 21
 and candles
6, 22
. Even wood untreated with any 
chemical additives generates harmful substances when burned, and the same is true for moxa 
produced from natural mugwort leaves alone. In this study we detected harmful substances released, 
albeit in very small amounts, from moxa used clinically in Japan. These harmful substances are 
invariably generated upon combustion, although varieties and quantities vary according to substance. 
This becomes problematic when such quantities exceed standards. According to Mo.F et al.
8
 . 
combustion of Chinese moxa sticks releases “toluene, xylene, formaldehyde, and benzene.” 
Simulations assuming Chinese clinical use resulted in high concentrations for some substances.    
 
For this reason, we determined it necessary to study the question of exposure in Japanese clinical 
practitioners of moxibustion exposed to the smoke for long periods of time. In particular, our 
analysis focused on 1,3-butadiene, the substance released in greatest quantities, in usage simulations 
modeled on the size of Japanese therapy rooms as well as moxa size, shape, and quantity. Our 
calculation assumed a moxa combustion rate of 63%, as recently in Japan 40-mg moxa cones are 
often removed from the skin once the patient feels heat in order to avoid scarring. The 63% figure 
was obtained by precisely measuring out about 40 mg of S2 moxa, igniting it on the back of the hand, 
then extinguishing it with nitrogen gas just prior to the heat becoming painful. The combusted 
portion was then removed, the non-combusted portion weighed, and the two weights used to 
calculate the percentage of moxa burned. This process was repeated three times to obtain the 63% 
combustion rate for S2 moxa.  
 
Our measurement and simulation results have shown that quantities of harmful substances released 
upon combustion of moxa during normal clinical therapy of Japan are below maximum levels, and 
hence are safe for both patient and practitioner. However, benzene and other harmful substances are 
present in moxa smoke, so measures to maintain an appropriately safe work environment must be 
practiced. Such measures may include installing ventilation equipment or manually ventilating the 
room sufficiently after each therapy session to reduce indoor air concentrations present at the 
beginning of each session. 
 
In Chinese practice
9
, extremely large quantities of medium-refined moxa sticks are regularly used 
for therapy, resulting in different levels of harmful combustion products compared to Japan. A report 
cites five doctors using 24,000 moxa sticks over the course of a single year. Further, moxa sticks are 
wrapped in paper, which also burns during therapy. Moxa sticks are also compressed, leading to 
more incomplete combustion due to lack of available oxygen inside the stick. These differences 
should be studied in more detail going forward. In addition, since incense is used in Japanese Tenkyu 
therapy to ignite the moxa, incense smoke should be subjected to the same analysis as the moxa 
itself.  
Finally, though the exposure evaluation was found feasible only by simulation in this study, it would 
be necessary to examine the density of harmful combustion products in the actual clinical 
environment in the future. 
 
8. Conclusions 
We studied the safety of combustion products in smoke produced by burning moxa used in Japanese 
moxibustion therapy according to qualitative and quantitative analysis of three common types of 
moxa, each with a differing level of refinement. Harmful substances were detected, although in 
extremely small quantities that fell below national safety standards according to both detector tube 
measurement and volatile organic compound analysis. A simulation was performed on indoor air 
concentrations of 1,3-butadiene, and levels were found safely within applicable indoor environment 
standards.  
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Figure captions 
Figure 1: Moxa sizes in Japan depending on treatment methods 
Different levels of purity and sizes are used in Japan depending on treatment method. This 
figure shows three types of moxa. 
Figure 2: Schematic of combustion testing apparatus 
This schematic shows the process from moxa combustion to gas collection.  
Figure3: Sample 1 moxa shaped into two 1-mg cones each placed side by side   
This figure shows 1-mg samples on the combustion chamber platform.  
Figure 4: Samples 2 and 3 shaped into 40-mg cones 
This figure shows 40-mg samples on the combustion chamber platform.  
Figure 5: Combustion methods for moxa cones using the combustion chamber 
This figure shows details of the process used in the combustion chamber.  
Figure 6: 1,3-Transition of butadiene concentration by moxibustion in the therapy room 
This figure shows simulated substance levels in therapy rooms. 
Figure 7: Algorithm for average air concentration of exposure duration 
This is the formula for calculating average air concentration of exposure duration in 
therapy room simulation.  
Figure 8: Algorithm for concentration during use 
This is the formula for calculating concentration during use in therapy room simulation. 
Figure 9: Algorithm for calculating average air concentration during post-use stay 
This is the formula for calculating average air concentration during post-use stay in 
therapy room simulation. 
  
Table legends: 
Table 1: Sample 3 qualitative results (102 compounds) 
This table lists all compounds detected in sample 3, which exhibited the largest number of 
combustion products in the experiment.  
Table 2: Results of detector tubes measurement 
CO and CO2 were detected in the qualitative analysis. These are regulated substances, so 
they were measured quantitatively as well.  
Table 3: Results of volatile organic compounds analysis 
This table shows concentrations of regulated substances (1,3-butadiene, benzene, toluene, 
ethylbenzene, and xylene) as well as estimated concentrations in an unventilated 20 m
3
 
room. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1: Moxa sizes depending on treatment methods in Japan  
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Fig. 2: Schematic of combustion testing apparatus 
  
 
 
 
 
 
 
 
 
Fig.3: Sample 1 moxa shaped into two 1-mg cones each placed side by side 
Fig. 4: Sample 2 and sample 3 shaped into 40-mg cones 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5: Combustion methods for moxa cones using the combustion chamber 
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Fig.6:Transition of 1,3-butadiene concentration by moxibustion in the 
therapy room 
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ii
ii
t
tN
N
Ca
Catii








 

exp11
Fig. 9: Algorithm for average air concentration during post-use stay 
  
 
Peak
No
Name of compound
(libraly serch results)
retention
time(min)
#1 Carbon dioxide 2.692
#2 Ethane 2.824
#3 1-Propene 3.346
#4 Propane 3.402
#5 Water 3.746
#6 Methane, chloro- 3.948
#7 Acetaldehyde 4.262
#8 1-Propene, 2-methyl- 4.762
#9 1,3-Butadiene 4.877
#10 Butane 5.028
#11 1-Butene 5.289
#12 Methane, bromo- 5.583
#13 1-Butene 5.704
#14 1-Propanamine 6.186
#15 Acetonitrile 6.778
#16 Acrolein 7.184
#17 Acetone 7.537
#18 1-Pentene 8.348
#19 Furan 8.449
#20 2-Propenenitrile 8.679
#21 Pentane 8.928
#22 1,3-Butadiene, 2-methyl- 9.186
#23 2-Butene, 2-methyl- 9.657
#24 2-Butene, 2-methyl- 9.946
#25 1,3-Pentadiene, 10.092
#26 1,3-Cyclopentadiene 10.767
#27 Cyclopentylethyne 10.93
#28 Propanal, 2-methyl- 11.154
#29 Propanenitrile 11.289
#30 2-Butenal 11.741
#31 Cyclopentene 11.889
#32 2-Butanone, 3-methyl- 12.503
#33 Acetic acid 13.095
#34 1-Hexene 13.841
#35 Furan, 2-methyl- 14.127
#36 Hexane 14.48
#37 Furan, 2-methyl- 14.713
#38 Pentane, 3-methylene- 14.836
#39 Cyclopentene, 1-methyl- 15.133
#40 2,4-Hexadiene  15.615
#41 2-Butenal 15.876
#42 2-Propanone, 1-hydroxy- 16.26
#43 1,3,5-Hexatriene 16.507
#44 Butanal, 2-methyl- 17.084
#45 Cyclopentene, 3-methyl- 17.334
#46 Benzene 17.519
#47 Propanoic acid 18.027
#48 1,3-Cyclohexadiene 18.15
#49 2,3-Pentanedione 18.355
#50 Cyclopentanol 18.708
#51 Cyclohexene 18.882
#52 1-Heptene 19.314
Table 1: Sample 3 qualitative results (102 compounds) 
  
Peak
No
Name of compound
(libraly serch results)
retention
time(min)
#53 2-Propyn-1-ol 19.555
#54 Furan, 2,5-dimethyl- 19.734
#55 Heptane 19.903
#56 2-Cyclopenten-1-one, 3-methyl-20.102
#57 Pyrimidine 20.405
#58 Phenol 20.564
#59 Furan, 2,3-dihydro-3-methyl- 20.671
#60 Acetamide 20.887
#61 1H-Pyrrole, 1-methyl- 20.959
#62 Pyridine 21.263
#63 Pyrrole 21.389
#64 Disulfide, dimethyl 21.549
#65 3-Butene-1,2-diol 21.725
#66 Propanoic acid, 2-oxo-, methyl ester 22.028
#67 Toluene 22.933
#68 1,4-Cyclohexadiene, 1-methyl- 23.124
#69 Hexanal Aldehyde 23.713
#70 3-Furaldehyde 23.833
#71 1-Octene  24.083
#72 Pyridine, 2-methyl- 24.512
#73 2-Furancarboxaldehyde 24.652
#74 2-Propanone, 1-(acetyloxy)- 25.238
#75 2-Furanmethanol 25.339
#76 Ethylbenzene 26.155
#77 p-Xylene 26.352
#78 Quinone 26.657
#79 Styrene 26.795
#80 o-Xylene 26.921
#81 2-Cyclopenten-1-one, 3-methyl- 27.863
#82 Phenol 27.986
#83 Corylone 28.883
#84 Benzene, 1-methyl-4-(1-methylethyl)- 29.144
#85 2-Methylphenol 29.2
#86 Limonene 29.318
#87 Phenol, 4-methyl- 29.419
#88 3-Pyridinol 29.483
#89 N-Methyl-2-benzyloxyethylamine 29.64
#90 Pentanamide, 4-methyl- 29.752
#91 Phenol, 2-methoxy- 29.823
#92 Benzoic acid 30.425
#93 Phenol, 2-ethyl- 30.624
#94 1,2-Benzenediol 30.851
#95 Benzofuran, 2,3-dihydro- 31.152
#96 1,2-Benzenediol, diacetate 31.471
#97 1,3-Benzenediol 31.611
#98 CinnamicAldehyde 31.676
#99 Indole 32.534
#100 3-methoxy acetophenone 32.78
#101 Phenol, 2-(1-methylethoxy)-, methylcarbamate 33.081
#102 1,3-Benzenediol, 4-ethyl- 33.423
   
 
 
 
 
 
 
Table 2: Results of detector tubes measurement 
Table 3: Results of volatile organic compounds analysis 
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